Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Janumet (sitagliptin/metformin hydrochloride) and Janumet XR (sitagliptin/metformin hydrochloride extended-release) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

ADVERSE REACTIONS

Post-Marketing Experience
  • Arthralgia, myalgia, pain in extremity and back pain

 

-
-